CARECLIX HOLDINGS, INC.
CARECLIX HOLDINGS, INC. (SOLI): 1 pipeline candidate · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.2 months
D/E -1.19 · 0% dilution
Lead: Preclinical
1 candidate
N/A
N/A
A transparent, data-derived signal for CARECLIX HOLDINGS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$9K
Quarterly Burn
$226K
Runway
1.2 mo
Revenue
$546K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| panoxol | Preclinical |
Frequently asked questions
How many drug candidates are in CARECLIX HOLDINGS, INC.'s pipeline?
CARECLIX HOLDINGS, INC. (SOLI) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is CARECLIX HOLDINGS, INC.'s lead drug candidate?
CARECLIX HOLDINGS, INC.'s most advanced tracked candidate is panoxol (Preclinical) for Vascular health support.
What is CARECLIX HOLDINGS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CARECLIX HOLDINGS, INC. has approximately 1.2 months of cash runway.
Get the full picture on CARECLIX HOLDINGS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.